Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?
A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...
Principais autores: | Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1986
|
Registros relacionados
-
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie AGG
Publicado em: (2014-03-01) -
A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
por: Andrei Viktorovich Fonyakin, et al.
Publicado em: (2012-09-01) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Paula Tiili, et al.
Publicado em: (2021-01-01) -
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
por: Tommaso Sacquegna, et al.
Publicado em: (2015-12-01) -
Prevalence of oral anticoagulation in atrial fibrillation
por: Eduardo Bartholomay, et al.
Publicado em: (2014-09-01)